Susan M Abdel-Rahman1, Barry L Preuett. 1. Division of Pediatric Clinical Pharmacology and Medical Toxicology, The Children's Mercy Hospital and Clinics, Kansas City, MO 64108, USA. srahman@cmh.edu
Abstract
BACKGROUND: Trichophyton tonsurans is the foremost fungal pathogen of minority children in the U.S. Despite overwhelming infection rates, it does not appear that this fungus infects children in a non-specific manner. OBJECTIVE: This study was designed to identify genes that may predispose or protect a child from T. tonsurans infection. METHODS: Children participating in an earlier longitudinal study wherein infection rates could be reliably determined were eligible for inclusion. DNA from a subset (n=40) of these children at the population extremes underwent whole genome genotyping (WGG). Allele frequencies between cases and controls were examined and significant SNPs were used to develop a candidate gene list for which the remainder of the cohort (n=115) were genotyped. Cumulative infection rate was examined by genotype and the ability of selected genotypes to predict the likelihood of infection explored by multivariable analysis. RESULTS: 23 genes with a putative mechanistic role in cutaneous infection were selected for evaluation. Of these, 21 demonstrated significant differences in infection rate between genotypes. A risk index assigned to genotypes in the 21 genes accounted for over 60% of the variability observed in infection rate (adjusted r(2)=0.665, p<0.001). Among these, 8 appeared to account for the majority of variability that was observed (r(2)=0.603, p<0.001). These included genes involved in: leukocyte activation and migration, extracellular matrix integrity and remodeling, epidermal maintenance and wound repair, and cutaneous permeability. CONCLUSIONS: Applying WGG to individuals at the extremes of phenotype can help to guide the selection of candidate genes in populations of small cohorts where disease etiology is likely polygenic in nature.
BACKGROUND:Trichophyton tonsurans is the foremost fungal pathogen of minority children in the U.S. Despite overwhelming infection rates, it does not appear that this fungus infects children in a non-specific manner. OBJECTIVE: This study was designed to identify genes that may predispose or protect a child from T. tonsurans infection. METHODS:Children participating in an earlier longitudinal study wherein infection rates could be reliably determined were eligible for inclusion. DNA from a subset (n=40) of these children at the population extremes underwent whole genome genotyping (WGG). Allele frequencies between cases and controls were examined and significant SNPs were used to develop a candidate gene list for which the remainder of the cohort (n=115) were genotyped. Cumulative infection rate was examined by genotype and the ability of selected genotypes to predict the likelihood of infection explored by multivariable analysis. RESULTS: 23 genes with a putative mechanistic role in cutaneous infection were selected for evaluation. Of these, 21 demonstrated significant differences in infection rate between genotypes. A risk index assigned to genotypes in the 21 genes accounted for over 60% of the variability observed in infection rate (adjusted r(2)=0.665, p<0.001). Among these, 8 appeared to account for the majority of variability that was observed (r(2)=0.603, p<0.001). These included genes involved in: leukocyte activation and migration, extracellular matrix integrity and remodeling, epidermal maintenance and wound repair, and cutaneous permeability. CONCLUSIONS: Applying WGG to individuals at the extremes of phenotype can help to guide the selection of candidate genes in populations of small cohorts where disease etiology is likely polygenic in nature.
Authors: Abigail K Langton; Michael J Sherratt; Christopher E M Griffiths; Rachel E B Watson Journal: Biogerontology Date: 2011-04-02 Impact factor: 4.277
Authors: Anders Clemmensen; Klaus E Andersen; Ole Clemmensen; Qihua Tan; Thomas K Petersen; Torben A Kruse; Mads Thomassen Journal: J Invest Dermatol Date: 2010-04-29 Impact factor: 8.551
Authors: Jürgen Brinckmann; Nico Hunzelmann; Birgit Kahle; Jürgen Rohwedel; Jan Kramer; Mark A Gibson; Dirk Hubmacher; Dieter P Reinhardt Journal: Lab Invest Date: 2010-03-01 Impact factor: 5.662
Authors: Erik-Oliver Glocker; Andre Hennigs; Mohammad Nabavi; Alejandro A Schäffer; Cristina Woellner; Ulrich Salzer; Dietmar Pfeifer; Hendrik Veelken; Klaus Warnatz; Fariba Tahami; Sarah Jamal; Annabelle Manguiat; Nima Rezaei; Ali Akbar Amirzargar; Alessandro Plebani; Nicole Hannesschläger; Olaf Gross; Jürgen Ruland; Bodo Grimbacher Journal: N Engl J Med Date: 2009-10-29 Impact factor: 91.245
Authors: Damian M Kraus; Gary S Elliott; Hilary Chute; Thomas Horan; Karl H Pfenninger; Staci D Sanford; Stephen Foster; Sheila Scully; Andrew A Welcher; V Michael Holers Journal: J Immunol Date: 2006-04-01 Impact factor: 5.422
Authors: Michaela Auer-Grumbach; Martin Weger; Regina Fink-Puches; Lea Papić; Eleonore Fröhlich; Piet Auer-Grumbach; Laila El Shabrawi-Caelen; Maria Schabhüttl; Christian Windpassinger; Jan Senderek; Herbert Budka; Slave Trajanoski; Andreas R Janecke; Anton Haas; Dieter Metze; Thomas R Pieber; Christian Guelly Journal: Brain Date: 2011-05-15 Impact factor: 13.501
Authors: Shiva Marthandan; Steffen Priebe; Mario Baumgart; Marco Groth; Alessandro Cellerino; Reinhard Guthke; Peter Hemmerich; Stephan Diekmann Journal: Biomed Res Int Date: 2015-08-03 Impact factor: 3.411
Authors: Alexandra N Myers; Sara D Lawhon; Alison B Diesel; Charles W Bradley; Aline Rodrigues Hoffmann; William J Murphy Journal: PLoS Genet Date: 2022-02-14 Impact factor: 5.917
Authors: Mariolina Bruno; Vasiliki Matzaraki; Frank L van de Veerdonk; Vinod Kumar; Mihai G Netea Journal: Infect Immun Date: 2021-07-15 Impact factor: 3.441